Predicting Early Toxicity
The NUVISAN group is a Contract Research and Development & Manufacturing Organization (CRO/CDMO) with six sites in Germany and France as well as local experts situated in Latin America.
We offer unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain to our biotech startup, pharma, non-profit, and venture capital clients – from target identification to the patient.
Thanks to more than 40 years of experience and about 1,000 employees (incl. > 70 % industry experienced scientists and lab professionals), we know how to discover, develop, and bring the next generation medicines to market.Set Up A Phone Appointment